Compare ALKS & ATR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALKS | ATR |
|---|---|---|
| Founded | 1987 | 1992 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Plastic Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.7B | 8.5B |
| IPO Year | 2012 | 1995 |
| Metric | ALKS | ATR |
|---|---|---|
| Price | $48.17 | $133.21 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 4 |
| Target Price | $43.43 | ★ $170.25 |
| AVG Volume (30 Days) | ★ 1.6M | 455.4K |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 1.56% |
| EPS Growth | N/A | ★ 6.51 |
| EPS | N/A | ★ 2.48 |
| Revenue | $1,475,899,000.00 | ★ $3,777,181,000.00 |
| Revenue This Year | $24.26 | $5.18 |
| Revenue Next Year | $4.47 | $4.98 |
| P/E Ratio | ★ N/A | $53.60 |
| Revenue Growth | N/A | ★ 5.42 |
| 52 Week Low | $25.17 | $103.23 |
| 52 Week High | $55.67 | $146.24 |
| Indicator | ALKS | ATR |
|---|---|---|
| Relative Strength Index (RSI) | 43.53 | 54.87 |
| Support Level | $47.66 | $121.60 |
| Resistance Level | $51.25 | $136.65 |
| Average True Range (ATR) | 1.61 | 2.75 |
| MACD | -0.13 | -0.66 |
| Stochastic Oscillator | 6.63 | 42.83 |
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. Its sales are primarily from Europe (49% of sales) and the United States (28%), with China contributing 5% and other countries contributing 17%. It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.